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Remodeling of mitochondrial ultrastructure is a complex dynamic process that is critical 
for a variety of mitochondrial functions and apoptosis. Although the key regulators of this 
process - mitochondrial contact site and cristae junction organizing system (MICOS) and 
GTPase Optic Atrophy 1 (OPA1) have been characterized, the mechanisms behind this 
regulation remain incompletely defined. Here, we found that in addition to its role in 
mitochondrial division, metallopeptidase OMA1 is required for maintenance of contacts 
between the inner and outer membranes through a dynamic association with MICOS. 
This association is independent of OPA1, appears to be mediated via the MIC60 MICOS 
subunit, and is important for stability of MICOS machinery and the inner-outer 
mitochondrial membrane contacts. We find that such molecular organization is required 
for stability of respiratory supercomplexes, optimal bioenergetic output in response to 
cellular insults, and apoptosis. Loss of OMA1 affects these activities; remarkably it can 
be partially compensated for by an artificial MICOS-emulating tether protein that bridges 
the inner and outer mitochondrial membranes. Our data show that OMA1-mediated 
support of mitochondrial ultrastructure is required for maintenance of mitochondrial 
 
 
architecture and bioenergetics under both basal and homeostasis-challenging conditions 
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Mitochondria are well known as being a powerhouse of the cell, but its functions 
go well beyond the production of energy (McBride et al., 2016.). In addition to the 
generation of energy by oxidative phosphorylation, mitochondria are responsible for 
initiating interferon type I and pro-inflammatory cytokines production. Thus making 
mitochondria the main organelle responsible for the formation of the inflammasome 
(Liao et al., 2008.). Mitochondria are also involved in the production of amino acid, 
Heme group , membrane phospholipid, calcium homeostasis (Bohovych et al., 2015.; 
Rossier, 2006.) hormone signaling(Klinger, 2008.), regulation of metabolism(Nuebel et 
al.,2016.), and the process of apoptosis and autophagy(Lindqvist et al., 2017.). Due to the 
strong oxidative stress, the mitochondria are under constant damage and given they play 
many essential functions in the cells; this damage must be minimized to maintain not 
only mitochondrial but also cellular homeostasis (Bohovych et al., 2016.). The damage 
caused by this stress is often controlled by processes of mitochondrial fusion and fission, 
which allows the mitochondria to maintain a correct morphology and functionality 
(Rainbolt et al., 2016). These are some of the processes involved in the control of 
mitochondrial quality that is regulated by metalloproteases, chaperones, GTPases, among 
other proteins (Bohovych et al., 2016.). 
Mitochondria are not static organelles; in fact, mitochondria form a dynamic 
network that is in constant process of fusion and fission to adapt the metabolic needs of 
the host cell. The mitochondrial network changes, in a more filamentous or fragmented 
form, aim to accommodate dysfunctional mitochondria with protein or mtDNA damage. 
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This is the basic principle of mitochondrial quality control (MQC). The MQC is precisely 
regulated and involves a large group of proteins and different forms of posttranslational 
modifications (Alavi et al., 2013.).  
The mitochondrial fission process involves the GTPase Drp1, which has its 
activity controlled by phosphorylation processes that can change the fission rate (Meuer 
et al., 2007.). The mitochondrial fusion process involves proteins located on the outer 
mitochondrial membrane (OMM) such as MFN1 and MFN2, and OPA1 that is located in 
the inner mitochondrial membrane(IMM) (Bohovych et al., 2015). Mutation or 
misregulation on MQC proteins are related with several metabolic disease and 
neuropathies (Lin et al., 2006.; Brandon et al., 2006.), as an example we have OPA1, 
mutations in the GTPase domain lead to Dominant Optic atrophy, a hereditary 
neuropathy that causes early blindness (Dotto et al., 2018.). 
OPA1 is expressed in eight different isoforms encoding proteins with 924-1014 
amino acids containing Mitochondrial target sequence (MTS) and a transmembrane 
domain (TM) in the N terminal region. After cleavage of the MTS, OPA1 is anchored in 
the IMM. This is the form known as “Long OPA1” (L-OPA1). Opa1 is a dynamin 
protein, and like other dynamin protein, it shows three main highly conserved domains: 
1- the GTPase domain near the N-terminus, 2-the middle region, 3- The GTPase effector 
domain. Near the GTPase domains, there are two different cleavage sites where OPA1 
can be proteolytically processed by two different metalloproteases, YMEL1 and OMA1, 
generating the soluble form of OPA1 or “Short form” (S-OPA1) (Rainbolt et al., 2016.; 
Dotto et al., 2018.)  
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In basal conditions, YME1l is active and cleaves OPA1 in position S2. OMA1 is 
only activated when the mitochondria are under stress conditions, and there is a 
depolarization of the mitochondrial membrane (Δψm). OMA1 will then cleavage OPA1 
in the position S1. Thus, there are different forms of S-OPA1 that vary depending on the 
isoform and the type of enzyme involved in the processing. 
The “OPA1 State Ready” oligomerizes into complexes involved in the 
stabilization of mitochondrial ridges, in the organization of respiratory complexes and 
immobilization of mtDNA. Under stress, the OPA1 oligomers are cleaved generating S-
OPA1; this process may induce fission mitochondria, leading to apoptosis. L-OPA1 and 
S-OPA1 alter the mitochondrial functions and morphology depending on their proportion 
Rainbolt et al., 2016.; Dotto et al., 2018.) . 
In this thesis, it is shown that the function of oma1 goes beyond the control of 
OPA1 levels. Using co-immunoprecipitation and proximity tagging techniques, it was 
possible to prove that oma1 interacts with the MIC60 protein, one of the components of 
the MICOS complex. This complex’s main function is to stabilize the external 
mitochondrial membrane with the internal mitochondrial membrane, being an important 
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Protease OMA1 Modulates Mitochondrial Bioenergetics and Ultrastructure 





Mitochondria are dynamic organelles with distinctive and complex architecture, 
wherein two disparate membranes, termed the outer mitochondrial membrane (OM) and 
the inner mitochondrial membrane (IM), form specific sub-compartments – the 
mitochondrial matrix and the intermembrane space (IMS). Unlike the OM, the IM is 
topologically heterogeneous and comprises two distinct regions: the inner boundary 
membrane (IBM), a planar membrane located in the vicinity of the OM, and the inner 
cristae membrane (ICM) – the region of IM that forms large invaginations termed cristae 
(Frey and Manella, 2000; Zick et al., 2009). These sack-like structures are highly 
enriched in respiratory complexes and stabilized by structures known as cristae junctions 
(Glickerson et al., 2003; Zick et al., 2009; Cogliati et al., 2016). Such architecture is at 
least in part mediated by a large protein complex known as MICOS (for mitochondrial 
contact site and cristae junction organizing system), which has been shown to have a 
crucial role in the formation and maintenance of cristae junctions and OM-IM contacts 
(van der Laan et al., 2016; Wollweber et al., 2017; Pfanner et al., 2014). MICOS resides 
in cristae junctions and encompasses at least six evolutionary conserved subunits: 
MIC60/Mitofilin, MIC19/CHCHD3, MIC25/CHCHD6, MIC27/APOOL, MIC26/APOO, 
and MIC10/MINOS1 (van der Laan et al., 2016). Other factors important for cristae 
ultrastructure include F1FO-ATP synthase (Davies et al., 2012; Daum et al., 2013) and 
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Optic Atrophy 1, OPA1 (Frezza et al., 2006; Yamaguchi et al., 2008; Cogliati et al., 
2013; Patten et al., 2014; Varanita et al., 2015). The latter is an IM-resident dynamin-like 
GTPase related to OM-associated GTP hydrolases DRP1 and Mitofusins 1 and 2, which 
have been shown to reciprocally regulate division and fusion of the mitochondrial 
network, respectively (Smirnova et al., 2001; Yoon et al., 2001; Chen et al., 2003; Song 
et al., 2009). OPA1 exists as a nearly stoichiometric mix of IM-anchored long (L-OPA1) 
and soluble IMS-localized short (S-OPA1) forms (Ishihara et al., 2006). In addition to its 
well-established role as a pro-fusion factor in the maintenance of the mitochondrial 
network (Ishihara et al., 2006; Song et al., 2009; MacVicar and Langer, 2016), OPA1 
variants form oligomers that are believed to connect cristae junctions, thereby segregating 
cristae content from the IMS and stabilizing respiratory supercomplexes (Cogliati et al., 
2013; Patten et al., 2014; Yoon et al., 2017). Interestingly, OPA1 and MICOS oligomers 
appear to be in physical contact and have been proposed to regulate cristae shape in a 
semi-cooperative manner (Darshi et al., 2011; Barrera et al., 2016; Schweppe et al. 2017; 
Glytsou et al., 2016;). 
Changes in cellular metabolic demands or homeostatic insults are known to 
correlate with changes in the mitochondrial network and ultrastructure (Hackenbrock 
1966; Cogliati et al., 2013; Patten et al., 2014; Plecita-Hlavata et al., 2016). A number of 
studies implicated OPA1 as a central component behind these alterations (Cogliati et al., 
2013; Mishra et al., 2014; Patten et al., 2014; Zhang et al., 2011). Although the 
significance of the L- and S-OPA1 variants in these events remains debated (Mishra et 
al., 2014; Anand et al., 2014; Lee et al., 2017), the OPA1-dependent IM remodeling is 
recognized as pivotal to several vital mitochondrial functions such as energy conversion 
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and apoptosis (Frezza et al., 2006; Yamaguchi et al., 2008; Tondera et al., 2009; Mishra 
et al., 2014; Anand et al., 2014; Korwitz et al., 2016). Two IM proteases, the i-AAA 
protease YME1L and the stress-activated peptidase OMA1 are critical regulators of IM 
dynamics in higher eukaryotes (Rainbolt et al., 2016; MacVicar and Langer, 2016; 
Levytskyy et al., 2017). They modulate the mitochondrial network via proteolytic 
processing of L-OPA1 variants under basal and stress conditions, respectively (Head et 
al., 2009; Ehses et al., 2009; Baker et al., 2014; Zhang et al., 2014; Anand et al., 2014; 
Wai et al., 2016). In the latter case, rapid proteolytic conversion of all available L-OPA1 
to the S-OPA1 form by OMA1 promotes fragmentation of the mitochondrial network – a 
critical event required for several downstream mechanisms such as apoptosis or 
mitophagy (Frezza et al., 2006; Yamaguchi et al., 2008; Rambold et al., 2011; Anand et 
al., 2014; MacVicar and Lane, 2014). As such, preservation of L-OPA1 variant through 
its overexpression or OMA1 depletion has been shown to stabilize the mitochondrial 
network, maintain normal cristae structure and exert anti-apoptotic effects (Anand et al., 
2014; Varanita et al., 2015). On the other hand – despite normal mitochondrial 
ultrastructure – OMA1-deficient mouse embryonic fibroblasts (MEFs) are 
bioenergetically compromised under conditions that demand maximal respiratory output 
(Quiros et al., 2012; Korwitz et al., 2016; Bohovych et al., 2015). OMA1 is also known 
to perform protein quality control functions and mediate the stability of respiratory 
supercomplexes, thus influencing mitochondrial energy metabolism (Desmurs et al., 
2015; Bohovych et al., 2015). An important unresolved question regards mechanistic 
aspects and the functional connection of these activities. 
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In the present study, we show that in addition to its role in mitochondrial fission, 
OMA1 is required for the organelle’s ultrastructural organization through its association 
with MICOS machinery. This interaction is likely mediated by the MIC60-MIC19 
subcomplex of MICOS and influences the recruitment of other MICOS proteins without 
significantly impacting mitochondrial fission/fusion machinery. We show that OMA1-
mediated MICOS stabilization is particularly important for optimal mitochondrial 
performance in response to cellular insults such as mitochondrial depolarization. 
Remarkably, in the absence of OMA1, these activities can be partially compensated for 
by an artificial tether protein that bridges the OM and IM, thereby emulating the tunable 
MICOS complex.  
Our results demonstrate that OMA1-mediated support of mitochondrial 
intermembrane contacts is required for modulation of mitochondrial bioenergetic in 
response to homeostatic challenges and suggest a previously unrecognized role for this 











MATERIALS AND METHODS 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Cell Lines and Cell Culture Conditions 
Wild type mouse embryonic fibroblasts and isogenic MEF oma1-/- cell lines were 
a kind gift from C. Lopez-Otin (Univ. of Oviedo). We have also obtained another set of 
WT and opa1-/- MEF cells from ATCC (CRL-2991 and CRL-2995 respectively). Human 
embryonic kidney HEK293T cells (ATCC CRL-3216) were a gift from Dr. Sathish 
Natarajan (Univ. of Nebraska-Lincoln). MEF cells were cultured in DMEM medium with 
addition of 10% fetal calf serum (Atlanta Biologicals), 10 mM glucose, 2 mM pyruvate, 4 
mM L-glutamine, 50 U/ml penicillin, with addition of 0.1% β-mercaptoethanol (all from 
Thermo Fisher Scientific). HEK293T cells were cultured in the same medium, albeit 
without the addition of β-mercaptoethanol. All cells were cultured in a humidified CO2 
incubator at 37oC, 95% air and 5% CO2 mixture. Cells were trypsinized for 5 min in 
0.05% trypsin after a wash with Ca2+- and Mg2+-free PBS. Cells were counted using 
Countess Cell Counter and Countess Cell Counting Slides (Invitrogen). Cell lines were 
regularly analyzed for mycoplasma contamination. 
Transient transfections were performed using Lipofectamine 3000 reagent 
(Thermo Fisher Scientific) according to the manufacturer-supplied protocol using the 
high range of the recommended Lipofectamine 3000 amounts (3 µl per well for 12-well 
plates, 7.5 µl per well for 6-well plates, and 44 µl per 10 cm2 dish). Experiments with 





Generation of MitoT-expressing Cell Lines 
The GFP-tagged mitoT construct was generated by fusing the N-terminal portion 
of SCO1 (amino acid residues 1-116), a 12 residues-long unstructured linker sequence 
derived from E. coli LacI, and the N-terminal region of TOM20 (amino acid residues 1-
20) followed by a 6xHis tag. This chimera was generated by an overlap extension PCR 








The resulting 468-bp product harboring BamHI and EcoRI restriction sites was cloned 
into the pcDNA3-eGFP vector (Addgene #13031). The resulting plasmid was validated 
by DNA sequencing, purified, and transfected into WT or oma1-/- MEF cells, and 
following 24 hours after transfection selected in 3 µg/ml puromycin for 1 week. The 
transfected cell population was subjected to discriminatory sorting based on GFP signal 
versus mock-transfected cells on FACS Aria II (BD Biosciences), and the resulting GFP-
positive cells were further selected for 1 week in a culture with 3 g/ml puromycin, 
resulting in a cell line stably expressing mitoT-GFP. Confocal microscopy and western 





Flow Cytometry Analyses 
Flow cytometry was performed either on FACSCalibur II (BD Biosciences) or 
Cytek DxP10 (Cytek Biosciences) flow cytometers recording a minimum of 10,000 
events per sample, with analysis of the resulting data using FlowJo 10 software (FlowJo 
Inc). 
Mitochondrial membrane potentials were determined using TMRM dye staining 
according to a previously described method (Rodriguez-Rocha et al., 2013). In brief, cells 
in confluent wells in a 12-well cell culture plate were subjected to either 2 M CCCP or 
mock for 1 hour, trypsinized, washed twice with PBS, resuspended in 1 ml of PBS, and 
stained with 50 nM TMRM for 15 minutes on ice. Cells were then pelleted at 400 xg, 
resuspended in fresh PBS, and measured on a Cytek DxP10 flow cytometer within 30 
minutes. TMRM fluorescence was measured using 561 nm excitation, and 580/20 nm 
emission filters. 
Annexin V presentation and cell viability were assessed after an 8-hour exposure 
to 1 µM staurosporin or mock-treatment using 7-AAD APC-Annexin Kit (BioLegend) 
according to manufacturer’s recommendations. 
Cytochrome c release was assessed after an 8-hour exposure to 1 mM 
staurosporin or mock using a cytochrome c release kit (EMD Millipore) per 
manufacturer’s recommendations. Upon necessity to avoid spectral overlap with the GFP 
fluorescence, the FITC-labeled anti-cytochrome c antibody supplied in the kit was 






For confocal microscopy imaging, cells were stained in 1 cm glass bottom dishes 
(MatTek Corp.) with 5 nM Hoechst 33342 (Thermo Fisher Scientific) and/or 5 µM 
Mitotracker DeepRed (Thermo Fisher Scientific) dyes in Phenol Red-free DMEM 
medium for 20 minutes in the dark, washed 2x with PBS, and supplemented with 2 ml of 
Phenol Red-free DMEM medium. The imaging was conducted using a Nikon A1R-Ti2 
confocal system (Nikon, Japan). Multicolor images were generated using ImageJ 
software (NIH) by merging appropriate channels after assigning colors to each of them 
(green for GFP channel, blue for Hoechst 33342, and red for MitoTracker DeepRed). 
For TEM, cells exposed to 2 µM CCCP or mock for 1 h were trypsinized, washed 
3x with PBS, fixed in 100 mM sodium cacodylate buffer pH=7.4 with 2.5% 
glutaraldehyde, and processed as previously described (Graham and Orenstein, 2007). 
TEM was performed on a Hitachi H7500 TEM microscope. Pictures were taken at 
10,000x and 25,000x magnification from three different grids per sample. Mitochondria 
on each photo were assessed for ultrastructure type, which was classified as 
abnormal/vesicular or normal. The number of mitochondria of each type was counted in 
each grid, and percent of total for each type was calculated in each sample. 
 
Biochemical Assays  
For cell lysis preparation 2 million cells per sample were lysed by tumbling at 4oC 
for 2 hours in NP-40 lysis buffer containing 1x protease inhibitors cocktail and 2 mM 
PMSF freshly added prior to the lysis. The lysates were supplemented with 6x Laemmli 
buffer containing 5% β-mercaptoethanol and after boiling for 5 min at 100oC were loaded 
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into a 10% polyacrylamide gel for subsequent immunoblot analysis. For IP, cells were 
grown to 90% confluence, and 24 hours after transfection were trypsinized, washed 3x 
with PBS, and lysed. Anti-Myc magnetic beads (Thermo Fisher Scientific, 88842), anti-
GFP magnetic beads (MBL International, D153-9), and isotype IgG magnetic beads 
(MBL International, M076-11) were used with the lysates according to manufacturer’s 
recommendations. Sucrose gradient separation of mitochondrial proteins was performed 
as previously described (Khalimonchuk et al., 2010) and analyzed by western blotting 
with relevant antibodies. Mitochondria (200 µg) were lysed using 20 M HEPES buffer 
pH 7.4 with 100 mM NaCl and 1% digitonin on ice for 15 minutes. The lysate was 
centrifuged at 20000 x g for 10 min. at 4oC.  150 µl of the supernatant was added to 40 µl 
of anti-Mic60 agarose beads containing 1500 µl of 20 µM HEPES buffer pH 7.4 with 10 
0mM NaCl and 0.1% digitonin and was kept rotating at 4oC for 16h. Proteins were eluted 
from the beads using 2x Laemilli buffer without any reducing agent.  
For blue native gel electrophoresis of mammalian mitochondria, Native PAGE Novex 
Bis-Tris Gel System and Native PAGE Novex 3-12% Bis-Tris Gels (Thermo Fisher 
Scientific) were used along with other reagents according to manufacturer’s 
recommendations for organelle protocols. Mitochondria were extracted from MEF cells 
as described previously (Chen et al., 2012), solubilized in a sample buffer containing 
0.5% digitonin and used as samples according to the manufacturer’s protocol. Proteins 
from the resulting gels were transferred to PVDF membranes (Thermo Fisher Scientific) 






Proteins were detected using the primary antibodies indicated in the Key 
Resources Table. Relevant protein bands were visualized using secondary horseradish 
peroxidase-coupled secondary goat-anti-mouse (Jackson ImmunoResearch) and goat-
anti-rabbit (Cell Signaling Technologies) secondary antibodies and chemiluminescent 
reagents (Thermo Fisher Scientific).  
 
BioID Analysis 
The pcDNA3.1-mycBioID plasmid was a kind gift from K. Roux (Addgene 
#35700). Human OMA1 and human SURF1 (matched negative control) were amplified 
using Phusion High Fidelity DNA Polymerase (Thermo Fisher Scientific) from HEK293T 
cDNA library and subcloned into the plasmid using NheI and EcoRI restriction sites to 
create BirA fusion proteins. The plasmids were expressed in HEK293T cells, and 
proximity interactions were analyzed according to a previously described protocol (Roux 
et al., 2013). Briefly, 48 hours after transfection, 20 million transfected cells were lysed 
and tumbled overnight with Streptavidin magnetic beads (Thermo Fisher Scientific), after 
which the beads were washed 3x with lysis buffer, boiled, and subjected to SDS-PAGE. 
Abundant protein bands were extracted out of the gel and subjected to mass 
spectrometry detection on a QSTAR XL Hybrid LC/MS/MS (Applied Biosystems). 
Results were analyzed using Scaffold 4 (Proteome Software). 
 
Extracellular Flux Analysis 
The cells were seeded in parallel in two identical Seahorse cell culture plates 
(Agilent Technologies), one of which was used for the actual experiment, while the other 
was used for cell count for normalization purposes. Extracellular Flux experiments were 
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performed on a Seahorse XFe24 Analyzer (Agilent Technologies) using XF Cell Mito 
Stress Test and XF Glycolysis Stress Test kits (Agilent Technologies) per 
manufacturer’s protocols. Data were analyzed using manufacturer’s calculation 
templates for Microsoft Excel 365. Summary bar graphs were plotted in Microsoft Excel 
365 based on the data from the original analysis templates. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Unless stated otherwise, the data were analyzed in Microsoft Excel 365 using the 
Data Analysis package.  All data are shown as mean ± S.D., unless indicated differently. 
P values were calculated using paired two-tailed t-tests when analyzing paired samples 
and unpaired two-tailed t-tests when analyzing unpaired samples. P values less than 
0.05 were considered significant. Violin graphs were plotted in GraphPad Prism 4.  
 For image quantification, images on X-ray films were digitalized and analyzed 
using Image J software.  
 For BioID LC-MS/MS data analysis, the following stringency criteria for candidate 
protein acceptance were applied. First, common background proteins were discarded. 
Second, candidate proteins with less than three spectral counts were considered as low-
confidence hits and not pursued further. Third, candidate hits were checked against the 
CRAPome contaminant repository database (https://www.crapome.org) and unrelated 
mitochondrial control (SURF1) BioID analysis data to further eliminate nonspecific 








OMA1 associates with MIC60 component of MICOS complex 
In our effort to gain new insight into the physical interactome of OMA1, we screened for 
its physiologically relevant interacting partners using the recently developed BioID 
method (Roux et al., 2013). This non-biased approach involves fusing the protein of 
interest to promiscuous BirA biotin ligase, which specifically modifies proteins in the 
immediate vicinity to the bait. HEK293T cells expressing OMA1-BirA or a topologically 
matched SURF1-BirA fusion construct (non-specific binding control) were cultured to 
allow the modification, lysed and subjected to affinity purification of biotinylated 
proteins followed by their identification by LC-MS/MS (Supplementary Fig. S1A). 
Subsequent analysis of candidate hits eliminated known contaminants and non-specific 
interactors. One prey protein that withstood our elimination analysis was 
Mitofilin/MIC60, a core component of the MICOS complex. To validate this interaction, 
we used HEK293T cells expressing C-terminally Myc-tagged MIC60. 
Immunoprecipitation of epitope-tagged MIC60 also led to specific co-purification of 
endogenous MIC60 and OMA1, but not the abundant m-AAA protease subunit AFG3L2 
(Fig. 1A). We have also detected some amounts of OPA1, which has been previously 
reported to interact with MIC60 (Glytsou et al., 2016; Barrera et al., 2016). Reciprocally, 
endogenous MIC60 co-precipitated with the GFP-tagged OMA1 (Supplementary Fig. 
S1B). Consistent with these results, OMA1 and MIC60 high molecular weight pools co-
fractionated on sucrose density gradient (Fig. 1B). We also observed partial co-
fractionation of these proteins with OPA1 signal.  
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Because OPA1 is the substrate of OMA1, and OPA1 and MIC60 are known to 
interact physically, we wondered if OPA1 might be mediating OMA1-MIC60 interaction. 
To better understand how these proteins are interrelated, we carried out MICOS co-
purifications in mitochondrial lysates from wild type (WT), opa1-/- and oma1-/- MEFs. 
Similar to HEK293T mitochondria, immunosorbtion of MIC60 resulted in co-
precipitation of both OMA1 and OPA1 along with MIC19, MIC10 and MIC27 MICOS 
subunits in WT mitochondrial lysates (Fig. 1C and data not shown). Importantly, OMA1-
MIC60 interaction remained largely unperturbed in opa1-/- mitochondria, indicating that 
OPA1 is dispensable for OMA1 association with MICOS. Similarly, we found that OPA1 
retained its ability to interact with MIC60 in oma1-/- cells (Fig.1C). We also noted that 
loss of OMA1, and to a lesser extent OPA1, negatively impacted MICOS as reflected by 
impaired MIC60-MIC27 interaction in both opa1-/- and oma1-/- mitochondria. We 
conclude that OMA1 is associated with MICOS machinery independently of OPA1. 
 
Loss of OMA1 impacts mitochondrial structure upon uncoupling 
Our finding that OMA1 is physically associated with MICOS prompted us to 
revisit mitochondrial morphology and ultrastructure in OMA1-deficient cells. We first 
examined mitochondrial network morphology in WT and oma1-/- MEFs. Consistent with 
previous reports (Quiros et al., 2012; Anand et al., 2014; Korwitz et al., 2016), deletion of 
OMA1 did not significantly affect mitochondrial tubulation under basal conditions (Fig. 
2A). We then assessed the morphology of the mitochondrial network under mild 
uncoupling – the condition upon which oma1-/- MEFs are known to exhibit bioenergetic 
deficit (Bohovych et al., 2015). As expected under this condition, control MEFs showed 
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rapid fragmentation of mitochondrial network, reflecting OMA1-mediated proteolysis of 
L-OPA1. The oma1-/- cells predictably retained tubular mitochondria upon uncoupling. 
We noticed, however, that the mitochondrial network morphology was different from that 
observed in unstressed oma1-/- MEFs. Mitochondrial tubules were shorter and tended to 
form clump-like clusters in CCCP-treated oma1-/- cells (Fig. 2A). Steady-state levels of 
the OM fusion-and fission-mediating proteins were unchanged in these cells (Fig. 2B). 
As expected, in contrast to the WT cells, the CCCP-treated oma1-/- cells retained the long 
form of OPA1 (Fig. 2C). We next assessed the behavior of the IM GTPase OPA1 by two-
dimensional BN-PAGE and observed that uncoupled oma1-/- MEFs, unlike WT cells, 
partially retained high-mass OPA1 species suggesting these oligomers are primarily 
formed by the L-OPA1 (Fig. 2D). 
Because the above results do not fully explain mitochondrial network alterations 
seen in CCCP-treated oma1-/- MEFs, we posited these changes may be related to OMA1-
MIC60 interaction. We thus examined stability of MICOS high-mass complexes and 
steady-state levels of key MICOS subunits in cells lacking OMA1. Surprisingly, BN-
PAGE analysis revealed marked attenuation of high-mass MICOS complex in oma1-/- 
cells, irrespective of CCCP treatment (Fig. 2E and Supplementary Fig. S2), indicating 
that MICOS may be more labile under blue-native gel conditions in the absence of 
OMA1. Consistent with this notion, oma1-/- cells exhibited increased accumulation of a 
lower-mass MIC27-containing complex (Supplementary Fig. S2B), suggesting that the 
MIC60-MIC19 subcomplex is likely affected by OMA1 loss. We then examined steady-
state levels of key MICOS subunits and observed a slight decrease in the levels of MIC60 
in oma1-/- MEFs under both basal and stress conditions, which suggests this protein is 
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likely not a substrate of OMA1 (Fig. 2F). The steady-state levels of MIC27 subunit were 
unaltered. By contrast, steady-state levels of MICOS subunits MIC19, MIC13 and 
MIC10 were decreased in oma1-/- cells relative to WT control in both basal and CCCP-
uncoupled conditions (Fig. 2F).  
We hypothesized that such an impediment may be affecting the architecture of 
IBM and/or IBM-OM contact sites (Supplementary Fig. S2A), thereby contributing to the 
altered mitochondrial morphology seen in stressed oma1-/- cells (Fig. 3A). To test this 
postulate, we examined mitochondrial ultrastructure in normal and CCCP-stressed oma1-
/- MEFs by transmission electron microscopy (TEM). In line with previous reports 
(Quiros et al., 2012; Anand et al., 2014; Korwitz et al., 2016), we found that about half of 
unstressed oma1-/- cells displayed mitochondrial ultrastructure similar to that of WT 
MEFs. Interestingly, however, in our hands a significant fraction of analyzed oma1-/- 
MEFs (~51%) exhibited defective cristae ultrastructure (Fig. 3B). Of note, we also 
observed a small fraction (~14%) of WT cells exhibiting altered cristae morphology – 
likely due to sample preparation and sectioning conditions. Furthermore, TEM analysis 
of CCCP-treated oma1-/- MEFs revealed that unlike in WT, ~70% of mitochondria in 
OMA1-deleted cells displayed defective cristae ultrastructure upon uncoupling (Fig. 3C). 
One particularly pronounced alteration included the appearance of onion-like cristae that 
were fully detached from the OM. Such ultrastructural changes are comparable to those 
described in cells depleted for MICOS subunits (Supplementary Fig. S3 and Glytsou et 
al., 2016) or harboring catalytically dead OPA1 (Lee et al., 2017) and are consistent with 
our predicted model outlined in Fig. 3A. Altogether, these results suggest that OMA1-
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MICOS association is required for cristae positioning and/or remodeling, particularly 
during homeostatic insults. 
 
Emulation of OM-IM contact sites preserves mitochondrial architecture in 
stressed oma1-/- cells 
Our data suggest that integrity of OM-IM contacts may be critical for stress-
induced cristae remodeling. To validate this idea, we engineered a chimeric construct 
comprising the N-terminal portion of the IM protein SCO1 (residues 1-161), an 
unstructured 12 amino acids-long linker region and the transmembrane segment of the 
OM protein TOMM20 (residues 1-24), followed by a GFP tag (Fig. 4A). This construct, 
which we called mitoT, is designed to tether the outer and inner mitochondrial 
membranes, thereby emulating the structural function of MICOS at the IBM sites. 
Indeed, a similar chimeric tether has been previously shown to partially compensate for 
the loss of MICOS in yeast (Aaltonen et al., 2016). We generated stable oma1-/- MEFs 
expressing mitoT at levels that were well tolerated by the cells in question (Fig. 4B and 
C) and showed that this construct was exclusively localized to mitochondria (Fig. 4B). 
The expression of mitoT had no appreciable effect on survival or proliferation of oma1-/- 
cells, nor did it influence L-OPA1 processing (Supplementary Fig. S4A). Of note, in WT, 
but not in oma1-/- cells, the mitoT protein displayed a slightly faster migration pattern, 
suggesting that OMA1 might be involved in its processing (Supplementary Fig. S4B). 
Next, we examined the ultrastructure of oma1-/- [mitoT] cells under basal and 
stress conditions by TEM. MitoT expression resulted in slightly denser cristae in 
unstressed cells, relative to oma1-/- MEFs (Fig. 4D). More importantly, we observed 
fewer disorganized cristae: 18% in oma1-/- [mitoT] versus 50% in oma1-/- MEFs under 
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basal conditions and 45% in oma1-/- [mitoT] versus 70% in oma1-/- MEFs in CCCP-
treated cells (Fig. 4D and E). These data indicate that mitoT is at least in part able to 
maintain OM-IM contacts in OMA1-deficient mitochondria. Biochemically, the 
expression of mitoT in oma1-/- cells stabilized the high-mass MICOS complex (Fig. 4F) 
and restored normal steady-state levels of MIC60, MIC19 and MIC10 MICOS subunits 
(Fig. 4G), further suggesting that mitoT-mediated permanent contacts between the IM 
and OM result in stabilization of mitochondrial architecture in OMA1-deficient cells. 
 
MitoT-mediated OM-IM contacts stabilize respiratory complexes and alleviate 
bioenergetic deficit in oma1-/- cells 
Mitochondrial ultrastructure is important for the stability and optimal 
performance of respiratory supercomplexes (RSCs) (Cogliati et al., 2013; Lee et al., 
2017). We therefore wondered if the impaired stability of RSCs and bioenergetic deficit 
seen in oma1-/- cells (Bohovych et al., 2015) could be a consequence of impaired OM-IM 
connectivity. To test this scenario, we examined mitochondrial lysates from WT, oma1-/- 
and oma1-/- [mitoT] MEFs by blue-native gel electrophoresis. Consistent with our 
previous observations, the abundance and stability of higher order RSCs was decreased in 
oma1-/- MEFs under the conditions tested. We also observed accumulation of free 
Complex III dimer in oma1-/- mitochondria (Fig. 5A). By contrast, although oma1-/- 
[mitoT] cells still exhibited elevated levels of free Complex III, we found that mitoT 
expression partially stabilized the higher order RSCs in these cells (Fig. 5A). Steady-state 




 We next evaluated the physiological relevance of mitoT-mediated RSCs 
stabilization by measuring in vivo oxygen consumption rates (OCR) in WT, oma1-/- and 
oma1-/- [mitoT] cells cultured in galactose. This culture condition forces cells to rely on 
oxidative metabolism (Gohil et al., 2010), and OMA1-deficient MEFs exhibit signs of 
bioenergetic deficit when cultured in galactose-supplemented medium (Bohovych et al., 
2015). This condition does not significantly alter viability of these cells (Supplementary 
Fig. S5A). In line with our previous report (Bohovych et al., 2015), we found that oma1-/- 
MEFs were unable to maximize their bioenergetic output in response to CCCP-treatment 
(Fig. 5C, D). In contrast, the mitoT-expressing oma1-/- cells exhibited a nearly-WT 
bioenergetic profile - most notably being able to efficiently maximize their OCR in 
response to mild uncoupling (Fig. 5C, D). The observed effect does not appear to be 
merely due to an excess of the L-OPA1 form, as expression of the L-OPA1 S1 variant 
lacking OMA1 cleavage site (Mishra et al., 2014; Lee et al., 2017) in oma1-/- MEFs did 
not mitigate bioenergetic deficit in these cells (Supplementary Fig. S5B and C). In fact, 
we found that such genetic manipulation reduced basal OCR of oma1-/- cells 
(Supplementary Fig. S5C). These data indicate an additional mechanism is at play in 
OMA1-mediated regulation of bioenergetic output. 
Finally, we used tetramethylrhodamine (TMRM) staining to examine basal 
mitochondrial membrane potential in the respective cells. We found that OMA1-depleted 
cells exhibited lower TMRM fluorescence thereby reflecting decreased mitochondrial 
membrane potential (Fig. 6A). Interestingly, mitoT expression did not improve 
mitochondrial polarization in these cells, indicating that membrane tethering via mitoT 
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may not fully replace some functions related to mitochondrial ultrastructure and/or 
MICOS complex that are compromised in OMA1-deficient MEFs. 
Collectively, these results suggest that impaired RSCs stability and bioenergetic 
deficit in OMA1-deficient cells arise from impaired OM-IM contacts and altered 
mitochondrial ultrastructure. 
 
Anti-apoptotic effect of OMA1 deletion is linked to impaired membrane contacts 
Previous reports established that loss of OMA1 renders cells resistant to apoptotic 
stimuli and attributed this effect to attenuated mitochondrial fission and cytochrome c 
release due to impaired L-OPA1 cleavage (Jiang et al., 2014; Varanita et al., 2015; 
Korwitz et al., 2016). Our findings prompted us to revisit this model and test whether 
impaired OM-IM connectivity may also be contributing to an anti-apoptotic effect in 
oma1-/- cells. We thus examined Annexin V presentation and cytochrome c release – two 
key steps in the commencement of a classical apoptotic program – in WT, oma1-/- and 
oma1-/- [mitoT] MEFs treated with the apoptosis-inducing drug staurosporin. In line with 
previous reports (Jiang et al., 2014; Varanita et al., 2015; Korwitz et al., 2016), we 
observed that oma1-/- cells accumulated significantly less externalized Annexin V, 
relative to WT control (Fig. 6B and Supplementary Fig. S6A). Likewise, staurosporin-
treated oma1-/- MEFs displayed significant impairment in cytochrome c release as 
compared to WT cells (Supplementary Fig. S3B and Fig. 6C). Remarkably, mitoT 
expression partially restored both staurosporin-induced Annexin V presentation and 
cytochrome c release in oma1-/- MEFs (Fig. 6B and C). The expression of mitoT had no 
appreciable effect on mitochondrial fragmentation in the cells of interest (Supplementary 
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Fig. S7). We conclude that reversal of apoptotic resistance in oma1-/- [mitoT] cells is due 
to stabilized IM-OM contacts rather than enhanced mitochondrial fragmentation. 
These findings further suggest that OM-IM connectivity is important for stress-
associated membrane remodeling and initiation of the apoptotic program. Moreover, our 
data expand the current model of how OMA1 inactivation may relate to cellular apoptotic 






































Remodeling of mitochondrial membranes is now being recognized as an integral 
part of multiple physiological processes in eukaryotic cells. Although the key players 
involved in sculpturing and dynamic rearrangement of the OM and IM have been 
identified, their coordinated function and the factors that orchestrate these mechanisms 
remain largely unclear. Here, we show that IM-anchored metallopeptidase OMA1 is 
dynamically associated with the MICOS complex, thereby stabilizing IM-OM contact 
sites and facilitating their remodeling in response to homeostatic insults. Mechanistically, 
this association appears to be mediated by OMA1’s interaction with the MIC60 subunit 
of MICOS, which we identified by proximity labeling, direct co-purification and co-
fractionation analyses. Interestingly, similar to the recently reported MIC60-OPA1 
association (Glytsou et al., 2016; Barrera et al., 2016), this interaction has previously 
eluded identification by the recent high-throughput proteomic analysis of MICOS 
(Guarani et al., 2015; Schweppe et al., 2017), probably due to the low cellular abundance 
of OMA1. Of note, we have also observed limited interaction between MIC60 and OPA1. 
However, the results of co-purifications in opa1-/- and oma1-/- MEF cells indicate that 
OMA1 and OPA1 associate with MICOS independently of one another.  
What is the effect of OMA1 loss with respect to MICOS? Consistent with 
previous reports (Quiros et al., 2012; Anand et al., 2014; Korwitz et al., 2016), we 
observed that OMA1 deletion in MEFs did not result in any appreciable mitochondrial 
morphology under basal conditions. As expected, unlike the WT cells, oma1-/- MEFs did 
not exhibit fragmented mitochondrial networks upon mild uncoupling due to impaired L-
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OPA1 processing and preservation of OPA1 oligomers. We found, however, that stressed 
OMA1-deficient mitochondria tended to form tubules that were morphologically distinct 
from those observed in unperturbed cells. Further analyses revealed that high-mass 
MICOS complexes were less stable under native gel electrophoresis conditions in oma1-/- 
mitochondria even if cells were not challenged with an uncoupler. Accumulation of 
lower-mass, MIC27-containing complexes (Supplementary Fig. S2) likely reflects 
impaired association of MIC60-MIC19 subcomplex with other MICOS subunits known 
as the MIC10 subcomplex. Our data indicate a general nature of this defect, but suggest it 
becomes physiologically significant upon conditions of mitochondrial stress. In line with 
this notion are the outcomes of our mitochondrial ultrastructure analysis. We 
reproducibly observed that about half of oma1-/- MEF cells exhibited aberrant 
mitochondrial ultrastructure; this might be in part due to harsh EM sample preparation 
conditions, which we believe have helped to reveal this subtle phenotype. More 
importantly, mitochondria in uncoupled oma1-/- MEFs displayed gross ultrastructure 
alterations wherein the majority of cristae appeared to be dislocated from the OM and 
formed vesicle- or onion ring-like structures. Remarkably, the latter alterations strongly 
resemble ultrastructure defects observed in MICOS-depleted cells (Plecita-Hlavata et al., 
2016; Glytsou et al., 2016 and Supplementary Fig. S3). Altogether, these data suggest 
that OMA1-MICOS association is required for efficient ICM and/or IBM rearrangement 
in response to homeostatic insults. Although neither MIC60 nor other core MICOS 
subunits seem to be a bona fide substrate of OMA1, and the exact mechanistic aspect of 
this association awaits an in-depth investigation, our results indicate that in the absence of 
OMA1, MICOS complex appears to be more labile and thus impeded in its ability to 
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efficiently reorganize OM-IM contact sites in response to homeostatic insults. Such a 
model is consistent with our finding that expression of the OM-IM bridging mitoT tether 
substantially ameliorated uncoupling-induced ultrastructure abnormalities in oma1-/- 
cells. A possibility exists that some of the above effects might also be connected to the 
inability of oma1-/- mitochondria to rapidly produce S-OPA1. However, previous reports 
showing that L-OPA1 alone is sufficient to mediate mitochondrial dynamics and 
ultrastructure (Ishihara et al., 2006; Tondera et al., 2009; Anand et al., 2014; Lee et al., 
2017) and that cells expressing a non-cleavable L-OPA1 variant do not appear to exhibit 
vesicular cristae (Lee et al., 2017) argue against this scenario.  
What is the physiological role of OMA1-MICOS association? Results of our 
experiments with the mitoT membrane tether indicate this association is required for 
stabilization of respiratory supercomplexes and optimal respiratory output in response to 
physiological challenges. These data are consistent with a model wherein remodeling of 
both IBM and ICM ultrastructure and the maintenance of OM-IM connectivity are 
required to reorganize and/or stabilize respiratory complexes, thereby optimizing their 
performance to meet changing bioenergetic demands in response to physiological or 
stress stimuli (Mishra et al., 2014; Patten et al., 2014; Lee et al., 2017). Alternatively, 
OM-IM contacts may facilitate functions of certain carrier proteins, ultimately providing 
better substrate accessibility for RSCs. Our results also offer a plausible explanation as to 
how loss of OMA1 could impair RSCs stability and cause bioenergetic deficit in response 
to mild uncoupling (Bohovych et al., 2015; Quiros et al., 2012).  
Finally, our findings indicate that OMA1-MICOS mediated intermembrane 
connectivity is important for commencement of the apoptotic program. Earlier reports 
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established that preservation of L-OPA1 oligomers via L-OPA1 overexpression (Varanita 
et al., 2015) or OMA1 depletion (Quiros et al., 2012; Jiang et al., 2014; Korwitz et al., 
2016; Wai et al., 2016) results in an anti-apoptotic effect, presumably due to the 
maintenance of tight cristae junctions and subsequent obstruction of cytochrome c release 
from the intercristae space in response to apoptotic stimuli (Frezza et al., 2006; 
Yamaguchi et al., 2008; Varanita et al., 2015). Our data expand this model of apoptotic 
resistance of oma1-/- cells as follows. First, we observed that physiological insults to 
OMA1-deficient cells promoted formation of OM-disconnected yet locked cristae that are 
likely to encapsulate and retain the majority of available cytochrome c pools. Indeed, 
these results were consistent with the elevated resistance of oma1-/- MEFs to the 
apoptosis-inducing drug staurosporin, as indicated by the significant decrease in Annexin 
V-stained cells and enhanced retention of mitochondria-bound cytochrome c. Second, we 
found that enforcing OM-IM contacts in OMA1-deficient MEFs through mitoT tether 
expression was sufficient to curtail the cells’ resistance to staurosporin-induced 
apoptosis. In line with this finding we observed that mitoT-expressing oma1-/- MEFs 
exhibited increased cytochrome c release upon staurosporin treatment as compared to 
untransformed cells. Collectively, these results suggested an updated model wherein not 
only cristae junction tightness, but also IM-OM connectivity is important for molecular 
events preceding apoptosis initiation. Overall, these data further our mechanistic 
understanding of OMA1’s role in mitochondrial architecture, bioenergetics and cell 
death. 
While this paper was in revision, a report appeared demonstrating that MIC60 and 
MIC19 MICOS subunits are connected to the SAM50 core component of the OM sorting 
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and assembly machinery (SAM) complex via the MIC19 subunit to dynamically shape 
cristae architecture (Tang et al., 2020). Tang et al. showed that under certain 
homeostasis-challenging conditions, OMA1 protease can mediate the N-terminal 
cleavage of MIC19, thereby destabilizing SAM-MICOS association and impacting 
mitochondrial architecture. Although these data are generally in line with our results 
described in the present study, we were unable to obtain any evidence for OMA1-
mediated MIC19 cleavage, likely due to differences in sample isolation procedures 
(whole cell lysates vs. purified mitochondria) and/or types of antibodies and cell lines 
used. Therefore, the exciting new mechanism by which MICOS is dynamically regulated 














































Figure 1. Evolutionarily conserved interaction between OMA1 and MIC60. (A) 
HEK293T cells were transfected with MIC60-Myc construct or mock transfected. 
Mitochondrial lysates from the respective cells were pre-cleared with IgG beads and then 
immunoprecipitated with anti-Myc magnetic beads. Precipitated proteins from the initial 
sample [load (crude)], the sample following pre-clearing [load (PC)], the last wash, and 
the eluate were analyzed by western blot with indicated antibodies. The asterisk indicates 
a non-specific band. (B) Digitonin-solubilized mitochondria from HEK293T cells were 
fractionated in a 12-50% sucrose density gradient by centrifugation. Collected fractions 
were analyzed by immunoblotting with antibodies against indicated proteins. The asterisk 
indicates a non-specific band. (C) Mitochondrial lysates from indicated MEF cell lines 
were incubated with agarose beads-coupled anti-MIC60 antibodies. Immunoprecipitated 
proteins from the initial sample (load), unbound fraction (unbound), last wash (wash), 
and eluate were analyzed by western blot with indicated antibodies. The asterisk indicates 












Figure 2. Mitochondrial morphology in normal and stressed oma1-/- cells. (A) In vivo 
confocal microscopy of the mitochondrial network in wild type (WT) and oma1-/- MEF 
cells. Fibroblasts were treated with 2 µM CCCP and incubated for indicated times to 
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induce mild uncoupling, stained with the mitochondrial dye Mitotracker Deep Red and 
analyzed by confocal fluorescent microscopy. Representative images are shown. Scale 
bars, 20 µm. (B, C) Immunoblot analysis with indicated antibodies of cell lysates from 
the same samples as in A. In panel C, letters a-e denote OPA1 isoforms, with a and b 
representing the long form of OPA1, L-OPA1 and c-e representing the short form, S-
OPA1. Asterisks denote S-OPA1 forms generated via OMA1-mediated cleavage of L-
OPA1. (D) Two-dimensional native gel electrophoresis analysis of OPA1 oligomers in 
mitochondria from WT and oma1-/- cells treated with (CCCP) or without (Mock) CCCP. 
OPA1A and OPA1B denote high- and lower-mass OPA1 oligomeric species, 
respectively. (E) Mitochondrial lysates were subjected to one-dimensional blue native gel 
electrophoresis and analyzed by western blot with antibodies against MIC60 and the 
outer mitochondrial membrane protein VDAC (loading control). (F) Steady-state levels 




Figure 3. Stressed oma1-/- cells exhibit altered mitochondrial ultrastructure. (A) 
Schematic depiction of the predicted ultrastructure defect in MICOS-deficient cells. A 
situation wherein mitochondrial cristae junctions remain closed but the IM-OM contacts 
are impeded would result in the appearance of vesicle-like cristae detached from the OM. 
(B) Transmission electron microscopy imaging of mitochondrial ultrastructure in wild 
type (WT) and oma1-/- MEF cells incubated with (+CCCP) or without (Mock) 2 µM 
CCCP. Representative images are shown. Scale bars, 0.4 µm. (C) The number of cells 
bearing mitochondria with aberrant cristae from B was quantified. Error bars, mean ± 
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S.D. of n=3 biological replicates with 100 cells per replicate; ***p<0.001 by t-test 



















Figure 4.  Mitochondrial membranes-bridging chimera partially corrects 
ultrastructure defects in stressed oma1-/- cells. (A) Schematic depiction of the mitoT 
artificial tether construct. (B) In vivo confocal microscopy of the mitochondrial network 
and mitoT-GFP signal in oma1-/- MEF cells stably expressing mitoT construct. 
Representative images are shown for the GFP signal from the tagged mitoT construct 
(mitoT) and Mitotracker DeepRed (MTR). Scale bar, 20 µm. (C) Mitochondrial lysates 
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from cells expressing GFP-tagged mioT and control cells were analyzed by western 
blotting with anti-GFP antibodies. (D) Representative TEM micrographs of mitochondria 
from control and CCCP-treated oma1-/- MEF cells expressing mitoT. Scale bar, 0.4 µm. 
(E) The number of cells bearing mitochondria with normal and aberrant cristae from 
indicated cell lines was quantified. Error bars, mean ± S.D. of n=3 biological replicates 
with 100 cells per replicate; **p<0.01, ***p<0.001 by t-test. (F) Mitochondrial lysates 
from indicated cell lines were analyzed by BN-PAGE and immunoblotting with 
antibodies against MICOS subunits MIC60 and MIC19. (G) Steady-state levels of 






















Figure 5. MitoT expression stabilizes respiratory complexes and mitigates 
bioenergetic deficit in OMA1-deficient cells. (A) Mitochondrial lysates from the 
respective cells were subjected to native gel electrophoresis and analyzed by western blot 
with indicated antibodies. Red asterisks highlight destabilized respiratory 
supercomplexes, and green asterisks highlight partially stabilized respiratory 
supercomplexes. (B) Steady-state levels immunoblot analysis with indicated antibodies of 
mitochondrial lysates from the same samples as in A. (C and D) In vivo oxygen 
consumption rates (OCR) of indicated cell lines (50,000 cells/well) under basal, 
oligomycin A (OLA), FCCP and antimycin A + rotenone stimulated conditions were 
assessed by extracellular flux analysis. Cells were cultured in medium containing 10 mM 
galactose. Representative OCR graph is shown in C. Panel D focuses on FCCP-
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stimulated maximal respiration. Error bars, mean ± S.E. of n=3 biological replicates; 


















Figure 6.  MitoT expression ablates apoptotic resistance in oma1-/- cells.  (A) 
Mitochondrial membrane potential in the indicated cell lines was assessed by flow 
cytometry analysis of tetramethylrhodamine (TMRM)-stained cells. Error bars, mean ± 
S.D. of n=3 biological replicates; *p<0.05, **p<0.01, by t-test. (B, C) Flow cytometry 
analysis of indicated cell lines that were treated with or without 1 mM staurosporin to 
assess the percentage of viable/apoptosis-resistant (Q3: 7-AAD negative, Annexin V-
APC negative) cells (B) or cells with mitochondria-retained cytochrome c (C). Error bars, 

























Supplementary Figure S1. BioID analysis of OMA1 physical interactome.  (A) Top, 
Schematic depiction of OMA1-BirA construct used in BioID proximity labeling analysis. 
Bottom, List of relevant proteins identified by BioID proteomic analysis. (B) HEK293T 
cells were transfected with OMA1-GFP construct or mock transfected. Mitochondrial 
lysates from the respective cells were subjected to immunoprecipitation with anti-GFP 
magnetic beads. Precipitated proteins from the initial sample (load), unbound fraction 

























Supplementary Figure S2. Stability of high-mass MICOS complexes is compromised 
in oma1-/- cells. (A) Schematic depiction of MICOS machinery and its partner protein 
complexes forming an IM-OM contact site. Some proteins are not shown for simplicity. 
(B) Mitochondrial lysates from WT and oma1-/- fibroblasts were analyzed by blue-native 
gel electrophoresis and immunoblotting with antibodies against indicated MICOS 



















Supplementary Figure S3. MICOS-deficient cells exhibit altered cristae morphology 
characterized by concentric membrane stacks and lack of cristae junctions. 
Representative TEM images of mitochondria in WT (left) and MIC13 knockout (right) 













Supplementary Figure S4. Quantitative assessment of cell survival by flow cytometry. 
(A) Viability over indicated periods of time of WT and oma1-/- fibroblasts with or 
without stable mitoT expression. Cells (500,000) were seeded per well in a 6-well plate. 
Growth was monitored for 3 days until over-confluence was reached. Events (10,000) 
were counted using Hoechst 33342 and propidium iodide staining parameters; healthy 
cells were PI-negative and Hoechst 33342-positive. Hoechst 33342-negative cells were 
not accounted for.  Error bars, mean ± S.D. of n=3 biological replicates. (B) Steady-state 
levels of mitoT-GFP, OMA1, OPA1 and HSPD1 (loading control) in indicated cells that 
were incubated with or without 2 M CCCP. Note that mitoT undergoes additional 

























Supplementary Figure S5. Bioenergetic deficit in oma1-/- cells is not directly related 
to (A) Steady-state levels immunoblot analysis of OMA1, YME1L, GAPDH and Myc-
tagged OPA1 variant lacking S1 processing site (OPA1 S1) with relevant antibodies in 
mitochondrial lysates from indicated cells, with and without CCCP treatment. (B) 
Extracellular flux analysis of in vivo oxygen consumption rates in indicated MEF cells. 
Cells were cultured in medium containing 10 mM galactose, then transferred into 





A (OLA), FCCP and antimycin A + rotenone stimulated conditions. Error bars, mean ± 






































Supplementary Figure S6. Apoptotic resistance of oma1-/- cells. (A) Quantitative 
assessment of cell survival by flow cytometry. Indicated cells were cultured in 10 mM 
glucose or 10 mM galactose-supplemented medium and stained with propidium iodide 
(PI). Healthy cells were identified as PI-negative. Data represents means ±S.E. of 3 
biological replicates. (B) Flow cytometry analysis of healthy (Q3: 7-AAD negative, 
Annexin V-APC negative), early apoptotic (Q1: 7-AAD negative, Annexin V-APC 
positive), late apoptotic (Q2: 7-AAD positive, Annexin V-APC positive) and necrotic 
(Q4: 7-AAD negative, Annexin V-APC positive) cells. Data are presented as mean ±S.E., 





assessing cytochrome c release in healthy (Control) and 1 mM staurosporin-treated 
(+STS) WT and oma1-/- fibroblasts. Iso, isotype control used to monitor antibody 
specificity. 50,000 cells were analyzed in each experiment. Right: Quantitative analysis 
of mitochondria-bound cytochrome c in the cells of interest. Data are presented as mean 

























Supplementary Figure S7. Expression of mitoT does not induce mitochondrial 
fragmentation in oma1-/- cells. Representative merged in vivo confocal microscopy 
images of mitochondrial network (visualized with mCherry, red signal) and mitoT-GFP 
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